Ferroptosis: Frenemy of Radiotherapy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25073641 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lisa Kerkhove und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium. Hauptthemen laut MEDLINE: Ferroptosis, Radiation Oncology, Radiation-Sensitizing Agents, Regulated Cell Death. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kom Op Tegen Kanker, Vrije Universiteit Brussel.
Abstract (Originalsprache)
Recently, it was established that ferroptosis, a type of iron-dependent regulated cell death, plays a prominent role in radiotherapy-triggered cell death. Accordingly, ferroptosis inducers attracted a lot of interest as potential radio-synergizing drugs, ultimately enhancing radioresponses and patient outcomes. Nevertheless, the tumor microenvironment seems to have a major impact on ferroptosis induction. The influence of hypoxic conditions is an area of interest, as it remains the principal hurdle in the field of radiotherapy. In this review, we focus on the implications of hypoxic conditions on ferroptosis, contemplating the plausibility of using ferroptosis inducers as clinical radiosensitizers. Furthermore, we dive into the prospects of drug repurposing in the domain of ferroptosis inducers and radiosensitizers. Lastly, the potential adverse effects of ferroptosis inducers on normal tissue were discussed in detail. This review will provide an important framework for subsequent ferroptosis research, ascertaining the feasibility of ferroptosis inducers as clinical radiosensitizers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.
ORCID-Profile: Lisa Kerkhove, Febe Geirnaert, Inès Dufait, Mark De Ridder
Förderung
- Kom Op Tegen Kanker
- Vrije Universiteit Brussel
Zitieren
APA
Kerkhove, L., Geirnaert, F., Dufait, I., & De Ridder, M. (2024). Ferroptosis: Frenemy of Radiotherapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073641
Vancouver
Kerkhove L, Geirnaert F, Dufait I, De Ridder M. Ferroptosis: Frenemy of Radiotherapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073641
BibTeX
@article{Kerkhove2024,
author = {Kerkhove, Lisa and Geirnaert, Febe and Dufait, Inès and De Ridder, Mark},
title = {Ferroptosis: Frenemy of Radiotherapy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25073641}
}
EUVIMED